No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Michael Dowling Northwell CEO Recognized as one of the “Most Influential People in Healthcare”

Editor: What To Know

  • Dowling's innovation, leadership and strong stance on social issues such as gun violence as a public health crisis as well as immigration, racial justice and the opioid epidemic, have also contributed to him earning a place on Modern Healthcare's prestigious list for the 15th consecutive year.
  • “This past year has shown us how vulnerable we still are to various pandemics facing health care, and how important it is to collaborate with our dedicated frontline workers and vanguard leaders to solve problems quickly in order to help our patients, families and communities through extraordinarily difficulty times,” Mr.
  • His vision and crisis management expertise helped manage the first coronavirus surge in New York City, establish one of the nation's most state-of-the-art testing centers at Northwell Health Labs, innovate new ways to alleviate supply shortages and utilize the entire integrated health system to improve patient care.

Michael J. Dowling, President and CEO of Nothwell Health, who leads the largest health care provider and private employer in New York State, has been named to Modern Healthcare magazine’s “100 Most Influential People in Healthcare,” ranking third overall.

In Modern Healthcare’s 2021 list, Michael J. Dowling ranked highest among 25 health care system or hospital CEOs nationwide. This year, Albert Bourla, chairman & CEO of Pfizer Biopharmaceuticals, ranked first and Stephane Bancel, CEO of Moderna, ranked second. National leaders ranked in this year’s list include Anthony Fauci, MD, director, chief medical advisor to the president of the National Institute of Allergy and Infectious  Diseases (No. 20), President Joe Biden (No. 34), and Xavier Becerra, U.S Secretary of Health and Human Services (No. 59).  Last year, Mr. Dowling ranked second on the health care magazine’s annual list only after frontline workers who were named first.

Mr. Dowling’s innovation, leadership and strong stance on social issues such as gun violence as a public health crisis as well as immigration, racial justice and the opioid epidemic, have also contributed to him earning a place on Modern Healthcare’s prestigious list for the 15th consecutive year. The health system recently held its third annual conference on gun violence December 15 with prominently known physicians, government officials and a family member whose loved one died as a result of gun violence. In addition, Northwell established a Center for Equity Care, funded a $1.3 million employee innovation challenge encouraging development of new processes and initiatives to improve health care, and implemented a broad range of employee health programs that engaged tens of thousands of staff. Modern Healthcare’s list includes the nation’s most prominent health care CEOs, elected officials and government administrators.

“This past year has shown us how vulnerable we still are to various pandemics facing health care, and how important it is to collaborate with our dedicated frontline workers and vanguard leaders to solve problems quickly in order to help our patients, families and communities through extraordinarily difficulty times,” Mr. Dowling said. “COVID-19 is ever-present and damaging. Gun violence continues to cripple us. And there are numerous other issues that are keeping our communities from thriving. It is our responsibility to partner with them to dramatically shift the situation in the right direction.”

In 2020, Northwell Health bore the brunt of the first wave of the pandemic with New York City as its epicenter. To date, the health system has treated more than 254,000 COVID patients across its network, including 64,000 COVID patients who were hospitalized. To further combat COVID-19 this year, Northwell offered COVID-19 vaccines to employees and residents across the New York metropolitan region, leveraging community partnerships. In October, Northwell Health’s staff reached 100 percent vaccination, due in part to the state’s vaccine mandate for health care workers.

“In 2021, we have made great strides in protecting our communities and country against coronavirus and its variants by making available COVID-19 vaccines to adults and children ages 5 and up, as well as booster shots,” said Mr. Dowling. “However, with approximately 200 million Americans vaccinated – about 61 percent of the population – the nation recently hit a grim milestone of 800,000 Americans who have died of the virus. The health system and our cities and towns across the country must step up efforts to continue education, testing, treatment and outreach to encourage as many vaccine-hesitant people to further stem the spread of coronavirus cases.”

In 2020, Mr. Dowling authored, “Leading Through a Pandemic: The Inside Story of Humanity, Innovation, and Lessons Learned During the COVID-19 Crisis, a book which continues to offer guidance to health care leaders on how to avoid the spread of future viral illness. His vision and crisis management expertise helped manage the first coronavirus surge in New York City, establish one of the nation’s most state-of-the-art testing centers at Northwell Health Labs, innovate new ways to alleviate supply shortages and utilize the entire integrated health system to improve patient care.

During his tenure as CEO, Mr. Dowling has developed Northwell Health into New York State’s largest health system with 22 hospitals, approximately 830 ambulatory and physician practices, and $15 billion in annual revenue. His ability to grow the health system into a vast clinical, academic and research enterprise builds on a legacy of innovation dating back to his 12 years of public service overseeing health, education and human services for former New York Governor Mario Cuomo.. To see the complete list of Modern Healthcare’s “100 Most Influential People in Healthcare,” go to: https://ModernHealthcare.com/100MostInfluential.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy